You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Lithium carbonate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for lithium carbonate and what is the scope of freedom to operate?

Lithium carbonate is the generic ingredient in seven branded drugs marketed by Noven Therap, Able, Alembic Ltd, Apotex Inc, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Hikma, Pharmobedient, Usl Pharma, Watson Labs, Solvay, Jds Pharms, Alembic, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Unique, Ani Pharms, Bayer Pharms, Pfizer, and Sun Pharm Inds Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for lithium carbonate. Twenty-one suppliers are listed for this compound.

Summary for lithium carbonate
Drug Prices for lithium carbonate

See drug prices for lithium carbonate

Drug Sales Revenue Trends for lithium carbonate

See drug sales revenues for lithium carbonate

Recent Clinical Trials for lithium carbonate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire DijonPHASE1
Massachusetts General HospitalPHASE1
Alzamend Neuro, Inc.PHASE1

See all lithium carbonate clinical trials

Pharmacology for lithium carbonate
Drug ClassMood Stabilizer
Medical Subject Heading (MeSH) Categories for lithium carbonate
Anatomical Therapeutic Chemical (ATC) Classes for lithium carbonate

US Patents and Regulatory Information for lithium carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmobedient LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 076243-001 Jun 27, 2002 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hikma Intl Pharms LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076490-001 Jun 17, 2003 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Heritage Pharma LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076170-001 Jun 10, 2002 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hikma LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 017812-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Able LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076382-001 Apr 21, 2003 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Noven Therap ESKALITH lithium carbonate CAPSULE;ORAL 016860-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Glenmark Pharms Inc LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 091544-001 Dec 27, 2010 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Lithium Carbonate

Last updated: September 5, 2025

Introduction

Lithium carbonate, a pivotal precursor in lithium-ion battery manufacturing and vital in treating psychiatric disorders, has experienced transformative shifts driven by technological advancements, regulatory environments, and evolving market demands. As a core element in energy storage solutions and mental health therapeutics, understanding its market dynamics and financial outlook is crucial for stakeholders across sectors.


Market Overview

Lithium carbonate is a chemical compound primarily used in two sectors: pharmaceuticals and renewable energy storage. The burgeoning adoption of electric vehicles (EVs) and portable electronic devices has greatly amplified demand for lithium-ion batteries, positioning lithium carbonate as a strategic mineral commodity. Simultaneously, its established role in managing bipolar disorder sustains consistent pharmaceutical demand.

The total global consumption of lithium carbonate was approximately 220,000 metric tons in 2022, with projections reaching 350,000 metric tons by 2030—at a compound annual growth rate (CAGR) of 5-7%[1]. This growth rate reflects rising EV adoption, technological innovation, and expanding applications in medicine.


Market Drivers

1. Electric Vehicle (EV) Proliferation

The transition toward sustainable mobility has placed lithium carbonate at the epicenter of energy storage innovation. Policy incentives, stricter emission regulations, and advances in battery technology generate robust demand.

2. Energy Storage Technologies

Renewable energy integration necessitates large-scale batteries, with lithium-ion chemistry leading the market. China, Australia, and South America are expanding lithium extraction, primarily from brine and hard-rock sources[2].

3. Pharmaceutical Demand Stability

Lithium carbonate continues to be a first-line treatment for bipolar disorder. Despite generic competition, steady prescription rates in developed markets sustain baseline demand.

4. Supply Constraints and Pricing Volatility

Limited spodumene and lithium-rich brine sources pose supply constraints, with prices surging during periods of heightened demand. The lithium spot price averaged $70,000 per metric ton in 2022, up from $12,000 in 2020, reflecting stockpiling and supply tightness[3].

5. Regulatory and Environmental Factors

Environmental concerns over lithium extraction methods, especially brine evaporation, influence project approvals and operational costs. Regulators in countries like Chile and Argentina impose stricter environmental standards, impacting supply growth.


Market Challenges

  • Price Volatility: Lithium carbonate prices are sensitive to demand-supply dynamics, geopolitical tensions, and technological bans, impacting revenue stability.

  • Environmental and Social Concerns: Extraction processes pose ecological risks, pressuring producers to adopt sustainable practices, which may elevate operational costs.

  • Technological Disruption: Advances in solid-state batteries and alternative chemistries could reduce lithium dependency, dampening long-term demand projections.


Financial Trajectory and Investment Outlook

1. Revenue Growth Projections

Major producers like Albemarle, SQM, and Tianqi Lithium project revenues to grow at CAGR rates of 6-8% over the next five years[4]. As demand intensifies, especially from EV battery manufacturers, prices are expected to stabilize at elevated levels, bolstering profit margins.

2. Capital Expenditure and Capex Trends

Producers are investing heavily in expanding lithium extraction capacities, with global lithium investment estimated at $4 billion annually[5]. These investments target both spodumene and lithium brine sources, aiming to meet surging demand.

3. Market Entry and M&A Activity

High market valuations and supply deficits have spurred mergers and acquisitions. Recent notable deals include Tianqi Lithium's acquisition of a stake in spodumene projects and strategic joint ventures between mining firms and chemical manufacturers.

4. Regulatory and Policy Impact on Financials

Government incentives for EV adoption and renewable infrastructure deployment directly influence lithium carbonate demand, translating into revenue growth for producers. Conversely, stricter environmental policies may constrict supply, affecting pricing power.

5. Price Forecasts and Investment Risks

Analysts anticipate lithium carbonate prices remaining above $50,000 per metric ton through 2025, with potential for further escalation if supply shortages persist[6]. However, significant risks include technological replacements, geopolitical disruptions, and environmental constraints influencing operational stability.


Future Market Trends

  • Sustainable Lithium Production: Adoption of eco-friendly extraction and recycling technologies could mitigate environmental concerns and enhance long-term supply stability.

  • Downstream Processing Innovations: Development of more efficient, cost-effective lithium refining processes can improve profitability margins.

  • Vertical Integration: Major players are increasingly integrating upstream (mining) and downstream (battery manufacturing) activities to control costs and secure supply chains.

Conclusion

Lithium carbonate stands at the nexus of energy transformation and healthcare. While supply-demand imbalances and environmental considerations present challenges, the outlook remains highly favorable owing to the rapid growth of EV markets and renewable energy adoption. Financial prospects for companies involved in lithium carbonate production are robust, with investment opportunities driven by technological innovation and strategic resource management.


Key Takeaways

  • The lithium carbonate market is poised for sustained growth driven by EV adoption, renewable energy storage, and stable pharmaceutical demand.
  • Price volatility remains a critical concern, requiring strategic risk management by stakeholders.
  • Supply constraints and environmental regulations are shaping project investments and operational costs.
  • Industry consolidation and technological innovation are influencing market structure and financial outcomes.
  • Long-term growth hinges on sustainable extraction practices, recycling advancements, and diversification into alternative battery chemistries.

FAQs

1. What factors influence lithium carbonate prices?
Lithium carbonate prices are primarily influenced by demand from battery manufacturers, supply availability from mining and brine sources, geopolitical stability, and technological developments in alternative energy storage solutions.

2. Which countries are the largest producers of lithium carbonate?
Chile, Australia, and China dominate global lithium carbonate production, accounting for approximately 80% of the world's supply[7].

3. How do environmental concerns impact lithium carbonate mining?
Environmental issues related to water use, habitat disruption, and chemical waste have led to stricter regulations, increased operational costs, and sometimes community opposition, affecting supply expansion.

4. What is the outlook for lithium carbonate demand in the next decade?
Demand is expected to grow at a CAGR of 5-7%, driven mainly by EV market expansion, renewable energy storage, and potential innovations in battery technology reducing dependency on lithium.

5. Are there any emerging substitutes for lithium carbonate?
While research into solid-state batteries and alternative chemistries (such as sodium-ion) is ongoing, lithium remains the dominant material for high-energy-density batteries. Substitutes are not yet commercially viable at scale.


References

[1] Benchmark Mineral Intelligence, "Global Lithium Market Report," 2022
[2] U.S. Geological Survey, "Mineral Commodity Summaries," 2022
[3] London Metal Exchange, "Lithium Price Analysis," 2022
[4] Company financial statements and investor presentations, 2022-2023
[5] International Energy Agency, "Mineral Market Investments," 2022
[6] Morgan Stanley, "Lithium Price Forecast," 2022
[7] USGS Mineral Commodity Summary, 2022

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.